This announcement is a separate document:
德琪醫藥-B：澄清及按照2022年受限制股份單位計劃實際授出受限制股份單位及根據2022年一般授權發行新股份
ANTENGENE-B: CLARIFICATION AND ACTUAL GRANT OF RSUs AND ISSUE OF NEW SHARES UNDER 2022 GENERAL MANDATE PURSUANT TO THE 2022 RSU SCHEME
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.